1. Home
  2. STRL vs IBRX Comparison

STRL vs IBRX Comparison

Compare STRL & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sterling Infrastructure Inc.

STRL

Sterling Infrastructure Inc.

HOLD

Current Price

$431.75

Market Cap

9.4B

Sector

Industrials

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$8.86

Market Cap

8.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRL
IBRX
Founded
1955
2014
Country
United States
United States
Employees
1740
N/A
Industry
Military/Government/Technical
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.4B
8.4B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
STRL
IBRX
Price
$431.75
$8.86
Analyst Decision
Buy
Strong Buy
Analyst Count
3
7
Target Price
$443.33
$12.57
AVG Volume (30 Days)
470.6K
31.2M
Earning Date
05-04-2026
02-23-2026
Dividend Yield
N/A
N/A
EPS Growth
13.42
38.71
EPS
9.38
N/A
Revenue
$957,958,000.00
$113,288,000.00
Revenue This Year
$20.76
$88.57
Revenue Next Year
$11.64
$146.98
P/E Ratio
$44.95
N/A
Revenue Growth
38.81
668.31
52 Week Low
$96.34
$1.83
52 Week High
$477.03
$12.43

Technical Indicators

Market Signals
Indicator
STRL
IBRX
Relative Strength Index (RSI) 57.71 55.55
Support Level $385.44 $2.27
Resistance Level $473.51 $12.43
Average True Range (ATR) 21.02 0.70
MACD -1.06 -0.20
Stochastic Oscillator 84.51 30.00

Price Performance

Historical Comparison
STRL
IBRX

About STRL Sterling Infrastructure Inc.

Sterling Infrastructure Inc is a construction company that specializes in heavy civil infrastructure construction and infrastructure rehabilitation as well as residential construction projects. The company operates in three reportable segments namely, Transportation Solutions, E-Infrastructure Solutions, and Building Solution. Transportation Solutions include highways, roads, bridges, airfields, ports, light rail, and others. Building Solution projects include concrete foundations for single-family homes. E-Infrastructure Solutions include the services which are provided to large, blue-chip companies in the e-commerce, data center, distribution center, and warehousing, energy, mixed-use, and multi-family sectors. The majority of the revenue is generated from E-Infrastructure Solutions.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: